Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

ForuMS: A Virtual Journal Club for MS Clinicians
FOCIS 2013: Improving Human Health Through Immunology
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Episode 21 with Dr. Paul Matthews discussing imaging in MS
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
FOCIS: Advanced Course in Basic & Clinical Immunology
Alpha/beta interferon is a neuronal growth factor.
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
JC polyomavirus mutants escape antibody-mediated neutralization.
Clarity Extension Study
Betaseron (Interferon Beta-1b) for SC Injection

Pages